Efavirenz: a new once-daily antiretroviral agent for HIV New Drugs and Disease Management 28 November 2012 Pages: 1 - 5
Erratum to Raloxifene: the first selective estrogen receptor modulator for postmenopausal osteoporosis Adis Editorial Erratum 28 November 2012 Pages: 5 - 5
Should all patients with cystic fibrosis receive dornase alfa? New Drugs and Disease Management 28 November 2012 Pages: 5 - 8
Methylphenidate still first line, but combination treatment often required in adults with attention deficit hyperactivity disorder New Drugs and Disease Management 28 November 2012 Pages: 8 - 12
Risperidone is expensive, but may be worth it Drug Economics and Quality of Life 28 November 2012 Pages: 12 - 16
